Index
TASC classifi cation 186
valve 296
valvular 302, 309
Lidocaine 73, 259, 276–7
Lifestyle 203, 214–5, 219, 221
Lipid, blood 214, 288
Lipodystrophy 241
Lipoprotein 188–9, 217–8, 219
atherogenic 192
levels 188
Lisinopril 227
Liver disease 189–90
LMWH 26, 37, 45, 68, 80, 131–2, 252
Loëffl er disease 241
Long QT syndrome. See LQTS
Losartan 227
Lovastatin 190
Low density lipoprotein cholesterol. See LDL-C
Low-molecular-weight heparin. See LMWH
Low-output syndrome 54–5, 69–72
LQTS 239, 277, 286–7, 289, 291
acquired 277
congenital 277
diagnosis 286
drug-induced 290
Lupus 241
LV 246, 274, 278, 285, 288
dilation 299–300
dysfunction 204, 208–9, 278–81, 284–6, 297, 299,
306–8
ejection fraction, see LVEF
pressure 299–300
size 299, 305
LVEF 17, 33–4, 40, 42–3, 61, 64, 74, 83, 137, 143, 146–7,
218, 220, 225, 227–31, 271–2, 275, 278–81, 284–6,
289, 298, 308
LVH 274
LVNC 237, 239
LVS 229, 234
LVSD 229, 234
MA 312, 330
Macroalbuminuria 210
Macrolide 190
MADIT 273, 279–80
MADIT-CRT trial 291
Magnesium 212, 225, 277, 282–3, 288, 290
salts 288
sulfate 277, 290
Magnetic resonance
angiography. See MRA
imaging. See MRI
Major ICD Secondary Prevention Trials 280
Management
BP 43, 95, 109, 112, 211
cardiac arrest 270, 275
cholesterol 187–95
dilated ascending aorta 300
DM 96, 110
HF, chronic 223, 233
hypertension 196, 203, 207, 210–2
lipid 43, 95, 109, 112–3, 187, 191, 195
patient 244–5, 255, 264–8, 270–1, 277, 285, 287, 294,
311, 339
perioperative 163–4
pharmacological 196, 249–51
physical activity 113
post-angiography 37
psychosocial 97
strategy selections 35–6
weight 25, 43–4, 94, 110, 113, 216
Markers
infl ammatory 194
insulin-resistance 194
MAT 255, 257, 265
MD 271, 285, 291
MDCT 336–7, 339–44
Measurements
hemodynamic 297, 306
intracoronary physiologic 129
Mediastinitis 140, 143
Medical Antiarrhythmic Treatment or Radiofrequency
Ablation in Paroxysmal Atrial Fibrillation
254
Meningococcus 241
Mercury 240
Mesoridazine 290
Metabolic syndrome 187–8, 192–4
Methadone 290
Methylmercury 218
Metolazone 228
Metoprolol 75, 163–4, 245, 268
succinate 209, 227
tartrate 227
Mexiletine 277
MI 25, 28, 32–42, 45–90, 92, 118, 128, 137, 141, 143, 149,
154–5, 159–60, 163, 167, 173, 175, 188, 197, 200,
216, 218, 220–1, 226–9, 232, 234, 256, 258, 272–3,
278–81, 283, 292, 294
acute 137, 139, 145, 149, 280, 288
index 280
low troponin 270, 276
prevention in women 220
prior 278–81, 285–6
remote 275
Microalbuminuria 195, 202, 210